This site is intended for health professionals only

Thursday 22 August 2019
Share |

Latest News

Dupilumab reaches primary and secondary endpoints in paediatric trial

Thursday 8th August 2019
A pivotal Phase III trial evaluating Dupixent® (dupilumab) in severe atopic dermatitis in children has met its primary and secondary endpoints. 
The topline data show that for children with severe atopic dermatitis (covering nearly 60% of their skin surface on average), adding Dupixent to standard-of-care topical corticosteroids (TCS) significantly improved measures of overall disease severity, skin clearing, itching and health-...
Thu, 9 May 2019
Familial chylomicronaemia syndrome is a debilitating disease caused by impaired function of the enzyme lipoprotein lipase, which causes high circulating levels of triglycerides in the body, leading to extreme abdominal pain and episodes of potentially fatal pancreatitis
Thu, 2 May 2019
Crohn’s & Colitis UK announces targeted research call into pain, one of the most debilitating symptoms of these conditions
Thu, 2 May 2019
The prospect of a CT scan can be scary for a child, but one student from the University of Salford in the UK is aiming to change that with her new business, ‘Stick with It’
Thu, 2 May 2019
Clinical Fellow Ben Shelley is driving forward the chronic pain trial at the Golden Jubilee Hospital in Scotland
Thu, 2 May 2019
Pancreatic Cancer UK has announced that they are investing £750,000 into developing the first simple test for pancreatic cancer by 2024
Thu, 2 May 2019
A de-escalation strategy omitting chemotherapy in the first line treatment of HER2 positive metastatic breast cancer was attempted in the PERNETTA trial
Mon, 29 Apr 2019
All opioid medicines in the UK will now carry addiction warnings on their labels, the health secretary has announced.